These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 32728930)

  • 1. Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA
    Moon ES; Elvas F; Vliegen G; De Lombaerde S; Vangestel C; De Bruycker S; Bracke A; Eppard E; Greifenstein L; Klasen B; Kramer V; Staelens S; De Meester I; Van der Veken P; Rösch F
    EJNMMI Radiopharm Chem; 2020 Jul; 5(1):19. PubMed ID: 32728930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA
    Moon ES; Van Rymenant Y; Battan S; De Loose J; Bracke A; Van der Veken P; De Meester I; Rösch F
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34201111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time.
    Moon ES; Ballal S; Yadav MP; Bal C; Van Rymenant Y; Stephan S; Bracke A; Van der Veken P; De Meester I; Roesch F
    Am J Nucl Med Mol Imaging; 2021; 11(6):476-491. PubMed ID: 35003886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the
    Läppchen T; Bilinska A; Pilatis E; Menéndez E; Imlimthan S; Moon ES; Afshar-Oromieh A; Rösch F; Rominger A; Gourni E
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy.
    Pang Y; Zhao L; Fang J; Chen J; Meng L; Sun L; Wu H; Guo Z; Lin Q; Chen H
    J Nucl Med; 2023 Sep; 64(9):1449-1455. PubMed ID: 37321827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Bal C
    Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
    Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
    Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma.
    Lai C; Cao R; Li R; He C; Wang X; Shi H; Qu C; Qian K; Song S; Chen WH; Cheng Z
    Mol Pharm; 2023 Aug; 20(8):4120-4128. PubMed ID: 37487027
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
    J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosynthesis and First Preclinical Evaluation of the Novel
    Wang C; Hu Z; Ding F; Zhao H; Du F; Lv C; Li L; Huang G; Liu J
    Front Chem; 2022; 10():939160. PubMed ID: 35991604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational assessment of a DATA-functionalized FAP inhibitor with facile
    Escudero-Castellanos A; Kurth J; Imlimthan S; Menéndez E; Pilatis E; Moon ES; Läppchen T; Rathke H; Schwarzenböck SM; Krause BJ; Rösch F; Rominger A; Gourni E
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3202-3213. PubMed ID: 37284857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
    Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
    J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
    Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy.
    Xu M; Zhang P; Ding J; Chen J; Huo L; Liu Z
    J Nucl Med; 2022 Jun; 63(6):952-958. PubMed ID: 34593598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [
    Greifenstein L; Kramer CS; Moon ES; Rösch F; Klega A; Landvogt C; Müller C; Baum RP
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Development of
    Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
    J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution, pharmacokinetics, dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Shang Y; Zhang G; Yao X; Lai C; Wang F; Zeng B; Liu E; Yuan H; Cheng Z; Jiang L
    Mol Imaging Biol; 2024 Aug; 26(4):729-737. PubMed ID: 38987449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
    Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
    J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [
    Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S
    Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.